{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:31:11Z","timestamp":1765373471087,"version":"3.46.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12308-025-00675-1","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:01:56Z","timestamp":1765368116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mantle cell lymphoma transformation to CD19-negative classic Hodgkin lymphoma as a novel mechanism of escape from CD19 chimeric antigen receptor T cell therapy"],"prefix":"10.1007","volume":"18","author":[{"given":"Yu","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bayerl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Mineishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Washburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"675_CR1","doi-asserted-by":"publisher","first-page":"106036","DOI":"10.1016\/j.phrs.2021.106036","volume":"175","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Wang T, Wang X, Zhang Y, Song S, Ma C (2022) Improving the ability of CAR-T cells to hit solid tumors: challenges and strategies. Pharmacol Res 175:106036","journal-title":"Pharmacol Res"},{"issue":"4","key":"675_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ccell.2017.03.002","volume":"31","author":"RG Majzner","year":"2017","unstructured":"Majzner RG, Heitzeneder S, Mackall CL (2017) Harnessing the immunotherapy revolution for the treatment of childhood cancers. Cancer Cell 31(4):476\u2013485","journal-title":"Cancer Cell"},{"issue":"10","key":"675_CR3","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","volume":"8","author":"RG Majzner","year":"2018","unstructured":"Majzner RG, Mackall CL (2018) Tumor antigen escape from CAR T-cell therapy. Cancer Discov 8(10):1219\u20131226","journal-title":"Cancer Discov"},{"issue":"16","key":"675_CR4","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1097\/CM9.0000000000000962","volume":"133","author":"LZ Li","year":"2020","unstructured":"Li LZ, Sun Q, Fang Y, Yang LJ, Xu ZY, Hu JH, Cao L, Huang JY, Hong M, Li JY, Qian SX (2020) A report on lineage switch at relapse of CD19 CAR-T therapy for Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia. Chin Med J (Engl) 133(16):2001\u20132003. https:\/\/doi.org\/10.1097\/CM9.0000000000000962","journal-title":"Chin Med J (Engl)"},{"key":"675_CR5","unstructured":"Coupland SE, Ott G, Sewell WA et al (2024) Mantle cell lymphoma In: WHO Classification of Tumours Editorial Board. Haematolymphoid tumours. Lyon (France): International Agency for Research on Cancer. (WHO classification of tumours series, 5th ed.; vol. 11).\u00a0 https:\/\/publications.iarc.who.int\/637.\u00a0Accessed 10 Aug 2025"},{"issue":"4","key":"675_CR6","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/bjh.18241","volume":"198","author":"K Zhu","year":"2022","unstructured":"Zhu K, Jamroz A, Huang S, Villa D, Freeman CL, Scott DW, Slack G, Sehn LH, Connors JM, Toze CL, Savage KJ, Gerrie AS (2022) Outcomes of Hodgkin variant Richter transformation in chronic lymphocytic leukaemia and small lymphocytic lymphoma in British Columbia. Br J Haematol 198(4):684\u2013692","journal-title":"Br J Haematol"},{"issue":"6","key":"675_CR7","first-page":"544","volume":"63","author":"T Ishida","year":"2022","unstructured":"Ishida T, Sato M, Kamoda Y et al (2022) Transformation of follicular lymphoma to classical Hodgkin lymphoma during observation. J Clin Hematol 63(6):544\u2013549","journal-title":"J Clin Hematol"},{"issue":"1","key":"675_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/PAI.0000000000000527","volume":"27","author":"S Kramer","year":"2019","unstructured":"Kramer S et al (2019) Mantle cell lymphoma with Hodgkin and Reed-Sternberg cells: review with illustrative case. Appl Immunohistochem Mol Morphol 27(1):8\u201314","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"6","key":"675_CR9","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/PAS.0000000000001834","volume":"46","author":"C Laurent","year":"2022","unstructured":"Laurent C, Syrykh C, Hamon M, Ad\u00e9la\u00efde J, Guille A, Escudi\u00e9 F, Jalowicki G, Fina F, Bardet A, Mescam L, Molina TJ, Dartigues P, Parrens M, Sujobert P, Besson C, Birnbaum D, Xerri L (2022) Resistance of B-cell lymphomas to CAR T-cell therapy is associated with genomic tumor changes which can result in transdifferentiation. Am J Surg Pathol 46(6):742\u2013753. https:\/\/doi.org\/10.1097\/PAS.0000000000001834","journal-title":"Am J Surg Pathol"},{"key":"675_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12320","volume":"7","author":"E Jacoby","year":"2016","unstructured":"Jacoby E, Nguyen SM, Fountaine TJ et al (2016) CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nat Commun 7:12320","journal-title":"Nat Commun"},{"key":"675_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/bjh.13562","volume":"171","author":"AG Evans","year":"2015","unstructured":"Evans AG, Rothberg PG, Burack WR et al (2015) Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells. Br J Haematol 171:205\u2013209","journal-title":"Br J Haematol"},{"key":"675_CR12","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1182\/blood.2020005123","volume":"136","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Orlando EJ, Wang HY et al (2020) Transdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenome. Blood 136:1980\u20131983","journal-title":"Blood"},{"issue":"4","key":"675_CR13","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/ijc.28422","volume":"134","author":"S Schneider","year":"2014","unstructured":"Schneider S, Crescenzi B, Schneider M, Ascani S, Hartmann S, Hansmann ML, Falini B, Mecucci C, Tiacci E, K\u00fcppers R (2014) Subclonal evolution of a classical Hodgkin lymphoma from a germinal center B-cell-derived mantle cell lymphoma. Int J Cancer 134(4):832\u2013843. https:\/\/doi.org\/10.1002\/ijc.28422","journal-title":"Int J Cancer"},{"issue":"11","key":"675_CR14","doi-asserted-by":"publisher","first-page":"1305657","DOI":"10.3389\/fped.2023.1305657","volume":"12","author":"S Negishi","year":"2024","unstructured":"Negishi S, Girsch JH, Siegler EL, Bezerra ED, Miyao K, Sakemura RL (2024J) Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma. Front Pediatr 12(11):1305657. https:\/\/doi.org\/10.3389\/fped.2023.1305657","journal-title":"Front Pediatr"},{"issue":"24","key":"675_CR15","doi-asserted-by":"publisher","first-page":"36854","DOI":"10.18632\/oncotarget.9210","volume":"7","author":"H Guan","year":"2016","unstructured":"Guan H, Xie L, Wirth T, Ushmorov A (2016) Repression of TCF3\/E2A contributes to Hodgkin lymphomagenesis. Oncotarget 7(24):36854\u201336864. https:\/\/doi.org\/10.18632\/oncotarget.9210","journal-title":"Oncotarget"},{"key":"675_CR16","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/leu.2008.12","volume":"22","author":"A Ehlers","year":"2008","unstructured":"Ehlers A, Oker E, Bentink S et al (2008) Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype. Leukemia 22:835\u2013841. https:\/\/doi.org\/10.1038\/leu.2008.12","journal-title":"Leukemia"},{"issue":"12","key":"675_CR17","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1182\/blood.2020005289","volume":"136","author":"F Nadeu","year":"2020","unstructured":"Nadeu F, Martin-Garcia D, Clot G, Diaz-Navarro A, Duran Ferrer M, Navarro A et al (2020) Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes. Blood 136(12):1419\u20131432","journal-title":"Blood"},{"issue":"17","key":"675_CR18","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1182\/blood-2017-04-779736","volume":"130","author":"CW Eskelund","year":"2017","unstructured":"Eskelund CW, Dahl C, Hansen JW, Westman M, Kolstad A, Pedersen LB et al (2017) TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoim munotherapy. Blood 130(17):1903\u20131910","journal-title":"Blood"},{"issue":"5","key":"675_CR19","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/bjh.17023","volume":"191","author":"JM Rodrigues","year":"2020","unstructured":"Rodrigues JM, Hassan M, Freiburghaus C, Eskelund CW, Geisler C, Raty R et al (2020) p53 is associated with high-risk and pin points TP53 missense mutations in mantle cell lymphoma. Br J Haematol 191(5):796\u2013805","journal-title":"Br J Haematol"},{"key":"675_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cancergen.2022.09.009","volume":"268-269","author":"R Garc\u00eda","year":"2022","unstructured":"Garc\u00eda R et al (2022) A t(11;14)(q13;q32)\/CCND1::IGH carrying progenitor germinal B-cell with subsequent cytogenetic aberrations contributes to the development of classic Hodgkin lymphoma. Cancer Genet 268\u2013269:97\u2013102","journal-title":"Cancer Genet"},{"issue":"2","key":"675_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/ejh.14103","volume":"112","author":"F Cai","year":"2024","unstructured":"Cai F, Zhang J, Gao H, Shen H (2024) Tumor microenvironment and CAR-T cell immunotherapy in B-cell lymphoma. Eur J Haematol 112(2):223\u2013235. https:\/\/doi.org\/10.1111\/ejh.14103","journal-title":"Eur J Haematol"},{"key":"675_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cells11121974","volume":"11","author":"DT Nguyen","year":"2022","unstructured":"Nguyen DT, Ogando-Rivas E, Liu R et al (2022) CAR T cell locomotion in solid tumor microenvironment. Cell 11:1974. https:\/\/doi.org\/10.3390\/cells11121974","journal-title":"Cell"},{"issue":"2","key":"675_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2025.101635","volume":"38","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Xu K, Wang Y (2025) Tumor microenvironment in CAR-T cell therapy for lymphoma. Best Pract Res Clin Haematol 38(2):101635. https:\/\/doi.org\/10.1016\/j.beha.2025.101635","journal-title":"Best Pract Res Clin Haematol"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00675-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-025-00675-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00675-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:01:57Z","timestamp":1765368117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-025-00675-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["675"],"URL":"https:\/\/doi.org\/10.1007\/s12308-025-00675-1","relation":{},"ISSN":["1868-9256","1865-5785"],"issn-type":[{"value":"1868-9256","type":"print"},{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study, formal consent is not required. The Institutional Review Board (IRB) does not require IRB approval for publication of case reports or images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, informed consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Consent for publication was obtained from the patient included in the report.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"59"}}